Co-stimulatory agonists as immunological adjuvants

Vaccine
Tom A BarrAndrew W Heath

Abstract

The considerable advances made in the fields of molecular biology, genomics, proteomics and protein engineering have led to the identification of a vast range of potential vaccine antigens for a host of man's most serious diseases. However, experience informs us that vaccines based on recombinant proteins and synthetic peptides lack the immunogenicity of the whole, killed pathogens used in traditional vaccines and, as such, clinical use of these immunogens remains negligible. In order to fully realize the potential benefits of recombinant antigen-based vaccines there is a pressing need to identify powerful adjuvants which can safely enhance these weak responses with a minimum of undesirable side effects. Adjuvant research represents a vibrant and fast moving field and recent developments suggest the goal of generating effective, safe and affordable ways of enhancing immune responses appears to be almost within our grasp. The purpose of this article is to review recent advances in adjuvant development using approaches that directly exploit the immune system's own co-stimulatory pathways to exert their function; with a particular emphasis on CD40 and CD28 based therapies.

References

Oct 27, 1975·Biochemical and Biophysical Research Communications·C MerserA Adam
Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·C A Janeway
Feb 1, 1994·The Journal of Experimental Medicine·L ChenK E Hellström
Jun 1, 1994·International Journal of Cancer. Journal International Du Cancer·C DöhringA Lanzavecchia
Jan 1, 1994·Cancer Biotherapy·A W Heath
Jun 1, 1997·Current Opinion in Immunology·C van Kooten, J Banchereau
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·A A HurwitzJ P Allison
Sep 10, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·H SwiniarskiM O'Toole
Jul 19, 2000·Current Opinion in Immunology·V E Schijns
Aug 6, 2000·Immunology·J Gordon, J D Pound
Oct 24, 2000·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·L DiehlR E Toes
Aug 24, 2001·Breast Cancer Research and Treatment·A MorrisA D Weinberg
Feb 28, 2002·Annual Review of Immunology·Beatriz M Carreno, Mary Collins
Mar 23, 2002·Biochimica Et Biophysica Acta·Tsuneyasu Kaisho, Shizuo Akira
Apr 16, 2002·Science·Ruslan Medzhitov, Charles A Janeway
Apr 16, 2002·Science·Polly Matzinger
Aug 20, 2002·Vaccine·Robert L Hunter
Oct 16, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ping-Ying PanShu-Hsia Chen
Feb 21, 2003·European Journal of Immunology·Jennifer CarlringAndrew W Heath
Apr 24, 2003·Immunology·Tom A BarrAndrew W Heath
Dec 4, 2003·Nature Reviews. Immunology·Oreste Acuto, Frédérique Michel
Dec 30, 2003·International Journal of Cancer. Journal International Du Cancer·Hsing-I HuangMi-Hua Tao
Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jacob BukczynskiTania H Watts
Mar 10, 2004·The Journal of Experimental Medicine·Cory L AhonenRoss M Kedl
May 12, 2004·Current Opinion in Immunology·Richard A KroczekAndreas Hutloff
Jun 3, 2004·Nature Reviews. Immunology·Kazuo SugamuraAndrew D Weinberg
Jul 6, 2004·Immunological Reviews·Dennis M KlinmanDaniela Verthelyi
Aug 17, 2004·Vaccine·Jennifer CarlringAndrew W Heath
Aug 19, 2004·Vaccine·Erik B Lindblad
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Carmela De SantoVincenzo Bronte

❮ Previous
Next ❯

Citations

Dec 22, 2009·Future Microbiology·Karl G KohlgrafKim A Brogden
Mar 9, 2010·Journal of Immune Based Therapies and Vaccines·Vijay Ns Bhagawati-PrasadAndrew W Heath
Aug 3, 2007·Expert Review of Vaccines·Cara K FraserJohn D Hayball
Jan 4, 2008·Journal of Drug Targeting·Bram SlütterWim Jiskoot
Feb 24, 2016·Journal of Immunology Research·Adi Essam ZareiElrashdy M Redwan
Jan 22, 2013·Enfermedades infecciosas y microbiología clínica·Alexander Batista-DuharteOliver Pérez
Apr 17, 2012·Developmental and Comparative Immunology·Lv-yun ZhuJian-zhong Shao
Jun 20, 2008·Fish & Shellfish Immunology·Chris Secombes
May 3, 2007·Immunology·Caterina Hatzifoti, Andrew W Heath
Nov 6, 2013·International Immunopharmacology·Xiaojuan ZhaoCui Liu
May 8, 2010·Biochemical and Biophysical Research Communications·Nicole MüllerHarald Wajant
Mar 20, 2013·International Immunopharmacology·Man-fei LiangRui-liang Zhu
Aug 17, 2011·Vaccine·Natasha A HynesRoy A Dalmo
Feb 6, 2007·Veterinary Immunology and Immunopathology·Geferson FischerTelmo Vidor
Jul 6, 2017·International Journal of Molecular Sciences·Ming GuoWenbin Zhan
Jan 1, 2011·Cancers·Ingeborg Streng-OuwehandYvette Van Kooyk
Jun 15, 2007·Nature Reviews. Microbiology·Bruno Guy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Advanced Drug Delivery Reviews
Tazio StorniPål Johansen
Vaccine
J C Aguilar, E G Rodríguez
Comparative Immunology, Microbiology and Infectious Diseases
Claude Leclerc
© 2021 Meta ULC. All rights reserved